Piperacilin/tazobaktam Teva 4 g/0,5 g prašek za raztopino za infundiranje Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

piperacilin/tazobaktam teva 4 g/0,5 g prašek za raztopino za infundiranje

teva pharma b.v. - piperacilin; tazobaktam - prašek za raztopino za infundiranje - piperacilin 4 g / 1 viala  tazobaktam0,5 g / 1 viala; tazobaktam 0,5 g / 1 viala - piperacilin in zaviralec laktamaz beta

Ertapenem Fresenius Kabi 1 g prašek za koncentrat za raztopino za infundiranje Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

ertapenem fresenius kabi 1 g prašek za koncentrat za raztopino za infundiranje

fresenius kabi deutschland gmbh - ertapenem - prašek za koncentrat za raztopino za infundiranje - ertapenem 1 g / 1 viala - ertapenem

Ertapenem AptaPharma 1 g prašek za koncentrat za raztopino za infundiranje Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

ertapenem aptapharma 1 g prašek za koncentrat za raztopino za infundiranje

apta medica internacional d.o.o. - ertapenem - prašek za koncentrat za raztopino za infundiranje - ertapenem 1 g / 1 viala - ertapenem

Ertapenem SUN Evropska unija - slovenščina - EMA (European Medicines Agency)

ertapenem sun

sun pharmaceutical industries (europe) b.v. - ertapenem natrij - bakterijske okužbe - ertapenem - treatmentertapenem sun is indicated in paediatric patients (3 months to 17 years of age) and in adults for the treatment of the following infections when caused by bacteria known or very likely to be susceptible to ertapenem and when parenteral therapy is required (see sections 4. 4 in 5. 1):- intra-abdominal infections- community acquired pneumonia- acute gynaecological infections- diabetic foot infections of the skin and soft tissue (see section 4. 4)preventionertapenem sun is indicated in adults for the prophylaxis of surgical site infection following elective colorectal surgery (see section 4. upoštevati je treba uradne smernice za ustrezno uporabo protibakterijsko agenti.

Zinforo Evropska unija - slovenščina - EMA (European Medicines Agency)

zinforo

pfizer ireland pharmaceuticals - ceftaroline fosamil - community-acquired infections; skin diseases, infectious; pneumonia - antibacterials za sistemsko uporabo, - zinforo is indicated for the treatment of the following infections in neonates, infants, children, adolescents and adults: , complicated skin and soft tissue infections (cssti), community-acquired pneumonia (cap) , consideration should be given to official guidance on the appropriate use of antibacterial agents.